News
Neurocrine Biosciences shares new data supporting Ingrezza's effectiveness in older adults with tardive dyskinesia. Read more ...
Experts explore strategies to support shared decision-making in the treatment of patients with tardive dyskinesia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback